NCT03603808 2025-07-16VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal LesionsAIDS Malignancy ConsortiumPhase 2 Completed35 enrolled
NCT03499795 2023-07-14VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2Inovio PharmaceuticalsPhase 2 Completed23 enrolled 19 charts